Skip to content

Salivary mucins in patients with salivary gland tumors

Salivary mucins in patients with salivary gland tumors - Salivary mucins in patients with salivary gland tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33922
Enrollment
130
Registered
2009-06-10
Start date
2009-07-21
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

salivary gland neoplasia

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients with a salivary gland tumor

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Expression and glycosylation and sialylation of mucines in salivary gland tumors, correlated to the presence of these mucins in saliva. Mucin in saliva of patients with salivary gland tumors, in comparison with normal controls.

Secondary

MeasureTime frame
none

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)